FDA Inspection
Acrotech Biopharma Inc.Acrotech Biopharma Inc. – FDA Inspection, Jan 19, 2023
Record Details
This FDA Inspection record concerns Acrotech Biopharma Inc., with an inspection on January 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d8adac73-ddbc-4993-a60b-4ef35c107440
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1195306
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
- 21 CFR 314.80(d)Failure to submit scientific article
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
- 21 CFR 314.80(d)Failure to submit scientific article
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Acrotech Biopharma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2024 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
Other documents for Acrotech Biopharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.